Tag: Hepalys
Inventiva and Hepalys Pharma, Inc., sign an exclusive license agreement to develop and commercialize lanifibranor in Japan and South Korea – 09/20/2023 at 10:00 p.m.
Daix (France), Long Island City (New York, United States), Tokyo (Japan), September 20, 2023 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a biopharmaceutical company specializing in clinical development…